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Abstract: Objectives: Lactose intolerance is a
common public health problem with 5-100%
prevalance among different populations of
the world. Use of β-galactosidase to reduce
the lactose content in food or consumption of
special products of milk or exogeneous
lactase enzyme are among the approaches
taken to manage lactose intolerance.
Recombinant β-galactosidase as well as βgalactosidase derived from different sources
have variances in their bioefficiency.
Thermodynamic
properties
of
βgalactosidase determines the industrial
efficiency.

anion exchange chromatography. Purity was
assesed by SDS-PAGE and Western Blotting
and the native molecular weight was
determined by rate zonal sedimentation.

In this β-galactosidase from E. coli CSH-36, a
constitutive expressor of enzyme was
investigated for enzyme biofunctionality.

On further investigation of thermodynamics
of the reaction for the substrate lactose, E.
coli CSH-36 may serve as a new source for in
vivo and in vitro hydrolysis of lactose.

Methods: The enzyme was purified by cell
lysis, ammonium sulphate precipitation and

Introduction
Lactose intolerance due to intestinal lactase (βgalactosidase) deficiency is a common public health
problem with more than 60% prevalance in most parts of
the world (1). The disaccharide lactose is presents as a
natural component of milk and dairy products. In the
gastrointestinal tract, lactose is hydrolyzed by the enzyme
β-galactosidase into glucose and galactose. The lactase
activity decreases in most people at an age of 4 to 6
years. Lactose intolerance clinically presents with the
symtoms of bloating, flatulence, abdominal pain and
diarrhea. The approaches to alleviate lactose maldigestion
are numerous (2) Use of microbial β-galactosidases to
degrade lactose content in milk and dairy products is
among the approaches taken for management of
maldigestion (3). Protein engineering and genetic
manipulations are being used as a common approach to
obtain recombinant enzymes and strains with higher
efficiency of enzyme synthesis. However, there is

Results & Conclusions
E. coli β-galactosidase is characterized as a
410 kD protein consisting of 3 x 120 kD
trimeric subunits complexed to a 50 kD
peptide with a specific activity of 170 U/mg
protein and 17% yield with the applied
procedure. The Km app is 1 x 10-3 M for the
substrate ONPG being slightly lower than the
data in literature

Key Words: lactose intolerance βGalactosidase, E. coli, purification, kinetics.

significant misfolding in genetically engineered proteins
(4) as well as variances of post-transcriptional steps (5)
which disrupts biofunctionality. In E. coli, β-galactosidase
is coded by the lac operon. i gene codes for lac I being the
repressor protein of lac operon. i. mutant CSH36 is a
constitutive expressor of β-galactosidase. In other words
it is known to synthesize large amounts of βgalactosidase even in the absence of inducer, which leads
to increased yield of enzyme synthesis on induction.
Specifically, CSH36 lacks the functional tetramer of lac
repressor to bind to lac operator DNA sqeuence even
though it retains the oligomerization and IPTG binding
capacity (6). This study is designed to find out if there are
any structural changes reflected by kinetic observations in
β-galactosidase CSH36 to evaluate the catalytic integrity
of the enzyme derived from mutant source, under the
given conditions. The results will serve for evaluation of
CSH36 β-galactosidase as an alternative source for
lactose hydrolysis in milk.
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Materials and Methods
Bacterial Strain
E. coli K-12 strain CSH (E7074) ∆ [F’Lac I proA+B+)
(lac pro) sup E thi] (Cold Spring Harbor Laboratories) (7)
which is constitutive for the lac enzymes was used, as a
model, to study the structural impacts of lac i-mutant
phenotype on the catalytic fucntionality of βgalactosidase.
Growth Conditions
It is well-known that bacterial growth attained in
minimal medium causes a cell physiology and protein
composition markedly different from those in cells grown
in the presence of amino acids (8). In this study, 2YT
broth (16 g/lt tryptone, 10 g/lt yeast extract, 5 g/lt NaCl)
was selected as enriched media for growth. Cultures were
started from overnights grown at the same temperature,
namely 37˚C in LB medium (tryptone 10 g/lt, yeast
extract 5 g/lt). 400 ml CSH 36 culture in 2YT Broth was
grown to obtain a cell density of OD600=1.2. With prior
experience, this corresponds to the mid-exponential phase
to optimize balanced growth to standardize the metabolic
differences between batch cultures. For harvesting, cells
were centrifuged for 10 minutes at 10.000 G and the
pellet was stored frozen at -70˚C. A streak was applied on
LB-X gal agar (Tryptone 10 g/lt, yeast extract 5 g/lt, NaCl
5 g/lt, X-gal 40 µg 7ml) and LB agar for assesment of
purity. All chemicals were from Sigma Chemical Company
(St. Loius, MO, USA) unless otherwise indicated.
Purification of β-galactosidase
Cell lysis
All protein work was done at +4˚C. Frozen E. coli CSH
36 was resuspended in 0.05 M NTM buffer (0.01 M Tris.
HCI pH 7.6, 0.05 M NaCl, 0.01 M Mg Acetate, 0.01 Mβmercaptoethanol, 0.001 M Na2EDTA). Cells were
sonicated for three minutes in 30 socends successions and
a qualitative spot β-galactosidase assay was performed to
see efficiency of sonication. On decision of sufficient lysis,
the suspension was centrifuged for 15 minutes at 12.000
G and 0.8 ml of crude extract was saved at -20˚C for
quantitative enzyme assays, protein assays and
electrophoresis.
Qualitative Spot assay for β-galactosidase activity
A spot test was developed through modification from
the by Warren et al (9). Briefly, 200 µl of sonicated cell
suspension was placed in an eppendorf tube and spun for
30 seconds at full speed in a microfuge. 20 µl of the
crude extract was mixed with 100 µl of ONPG (onitrophenyl-B-D-galactoside) and the assay was allowed
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to proceed for 60 seconds. 50 µl of 1M Na2 CO3 was
added and the intensity of orange color was scaled
between 1-5.
Ammonium Sulphate Precipitation
The method was similar to that described by Every
and Ashworth (10). Ammonium sulphate was added to
the crude extract to 60% saturation, stirred for 30
minutes and centrifuged 10 minutes at 12.000 G. On
observation of most of the β-galactosidase activity in the
pellet, the pellet was resuspended in one-tenth volume of
cold 0.05 M NTM. Solution was dialyzed against NTM
buffer using cellulose tubing permeable to particles of
10.000 Daltons.
Anion Exchange Chromatography
The material obtained from the salt precipitation step
is loaded on DEAE-Cellulose column (DE 52 anion
exchange cellulose resin, Whatman) collected as 1.5 ml
fractions and eluted with gradients of salt concentrations
(upto 0.5 M NaCl). The graph in Figure 1 illustrates the
elution profile of β-galactosidase, determined by
qualitative β-galactosidase assay and proteins estimated
by protein dye-binding assay (Bio-Rad).
Polyacrylamide Gel Electrophoresis
For the estimation of purification 7.5% SDS-PAGE
was ran at 60 V for 30 minutes followed by 150 V for 50
minutes as described by Laemmli (11). 2.5 mg of proteins
were loaded to each lane. Staining was done with
Commassia Blue as described elsewhere (12). Myosin
(205 kD), β-galactosidase (120 kD), phosphorylase B
(97.4 kD), bovine albumin (66 kD), ovalbumin (45 kD)
and carbonic anhydrase (29 kD) were used as molecular
weight markers.
Western Blot was done as previously described (13)
with 1/3000 dilution of the antibody (BoehringerMannheim Corp. USA) with 5 seconds exposure.
Rate Zonal Sedimentation
For the estimation of native size of the purified βgalactosidase a gradient of 5% sucrose in 0.05 M NTM
buffer was prepared in 2.2 ml ultracentrifuge tubes and
spun in the Beckman TL 100 in TLS55 swinging bucket
rotor for 3 hours at 55.000 rpm at 4˚C with brake. E.
coli alkaline phosphatase (MW 80.000), catalase (MW
250.00), and jack bean urease (MW 480.000) were used
as marker proteins. 100 µl fractions were collected and
assayed for the markers and β-galactosidase. Alkaline
phosphatase (14), catalase (15), and urease (16) assays
were done spectrophotometricaly as previously described
and the number of fractions were plotted against
molecular weight on a semi-log scale.
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fractions 89-105 displayed β-galactosidase activity,
determined by qualitative β-galactosidase assay.
Commassia blue satined SDS-PAGE in Figure 2 gives more
evidence of the discarded proteins on purification. The
prominent 120 kD band in lanes 7-10, matches in mass
with the pure β-galactosidase loaded on lane 11 as the βgalactosidase band on the marker lane. It is also observed
that most of the protein present in the crude extract was
eluted on batch additions of 0.1 and 0.2 M NaCl as
observed on lane 6 loaded with fraction 38 on

Characterization of the kinetic behaviour of the
enzyme
The appearant Km value was calculated by the double
reciprocal plot method of Lineweaver and Burk.
Results
Figure 1 demonstrates the elution profile of ionexchange chromatography. Only the protein peak at

Figure 1.

Ion exchange chromatography
protein and b-galactosidase
activity elution profile.

Table 1.

Crude extract (10 µl). Lane 2.
Supernatant (15 µl) Lane 3.
Supernatant (10 µl) Lane 4.
Pellet at 20% ammonium sulphate precipitation. Lane 5
Pellet at 30% ammonium sulphate precipitation. Lane 6.
Fraction 38. Lane 7. Fraction
92. Lane 8. Fraction 99. Lane
10. Fraction 101. Lane 11. bgalactidose. Lane 12. Protein
markers.

Figure 2.

Commassia stained SDS-PAGE
of fractions from protein purification steps.

OD 280
3
2.5
0.50 M NaCl

2
0.20 M NaCl
1.5

0.30 M NaCl
1

0.15 M NaCl

β galactosidase (+)

0.5
0
0

20

Crude Extract
Supernatant
Anion Exchange
Chronatography

12

40

60
Fraction #

80

Volume

Protein
mg/ml

Enzyme
U/ml

Specific
Activity

30
25
1

2.5
1.62
0.19

83.3
35.7
32.3

33.3
21.5
170

11

10

9

8

7

6

5

100

120

Purfication
Factor
1
1.3
5.1

4

3

% Yield

100
36
17

2

1

205 kD
120 kD
97.4 kD
66 kD

45 kD

29 kD
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comparison with figure 1. It is also important to notice a
50 kD band that shows up at fraction 92, however can
hardy be observed on later fractions most probably due
to decrease in concentration. This band is discussed later
in the text as a 4th subunit of β-galactosidase with
variation of post-translational modification under the
experimental conditions. In order to check if the 120 kD
band observed on SDS-PAGE corresponds to βgalactosidase molecule, 50 ng/µl protein concentration of
fraction 94 was run on a 7.5% SDS-gel and Western
transferred to be detected with anti-β-galactosidase
antibody. The image reveals not only the 120 kD band but
the 50 kD band as well to perfectly provide evidence of
the suggested molecular structural modifications, as seen
in Figure 3. Table 1 demonstrates the purification
scheme. It is worthwhile to note that the extract was
fairly pure from excess proteins as seen on SDS-PAGE.
The actual protein concentration decreased from 2.5
mg/ml in the crude extract to 0.19 mg/ml in the pool
after chromatography which counts for a decrease by a
factor of 13. However, the specific activity was increased
only by a factor of 5, indicating loss of enzyme activity
during the procedure. It has been stated that βgalactosidase from E. coli has a flat pH optimum, which
is somewhat dependent on the type of buffer used and on
the added ions (17). In the presence of alkali ions (sodium
ions inhibit the enzyme) which are necessary for the
activity of β-galactosidase and magnesium ions which
result in an increase in activity, the pH optimum of β-

120 kD

50 kD

Figure 3.

Western Blot of fraction 92 with anti-β-galactidose
antibody.

Molecular Weight Determination by Rate Zonal Centrifugation

B.gal
=410 kD

100 _

4.00

10.00

12.00

Fraction number
Figure 4.
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Specific activity of CSH36 β-galactosidase after each step of purification.
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Figure 5.
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_

_

4

6

galactosidase in phosphate buffer is 6.5. The activity is
said to be 85% in phosphate buffer and 90% in imidazole
buffer at pH 7.5 whereas it is 85% in imidazole buffer,
pH 8.0 β-galatosidases from other sources show
different pH optimum properties. This study was
conducted in 0.05 M NTM buffer pH 7.6. Especially after
the elution from ion-exchange chtomatography Na+
concentration of the solution medium increased to as high
as 0.5 N which is inhibitory on β-galactosidase. Figure 4
demonstrates the migration profile of β-galactosidase
obtained on rate zonal centrifugation. β-galactosidase
activity for the substrate ONPG is detected at 410 kD.
The appearant Km of β-galatosidase purified is calculated
as 1x10-3 from double reciprocal plot as seen in Figure 5.
Discussion
It is suggested that lactose intolerance does not
become cilinically appearant unless the susceptible person
attains a higher amount of dairy consumption. Thus
basically diminishing the daily intake is the simplest
approach in alleviating the symptoms. However being a
well-established calcium source as well as other nutrients
dairy products are irreplacable ingredients of natural
healthy diet. The other approach taken is maneuvers to
reduce the lactose content in food or consumption of
special products of milk and exogeneous lactase enzyme
(18). Among the available substitutes, yogurt prepared
by fermenting milk with Lactobacillus Bulgaricus, sweet
acidophilus milk, microbial lactase hydrolyzed milk, and
commercial lactase tablets can be counted (19). In the
study conducted to compare the relative efficiency of
these products, it was demonstrated that best response in
breath hydrogen levels was attained by yogurt,

_

2

_

0

_

_

0.0 _
-2

_

5_

8

10

hydrolyzed lactose tablets added whole milk and sweet
acidophilus milk in decreasing order. The main concern
influencing the product choice of the consumer is
product-acceptance. The same study indicates that
reservations for plain yogurt were due to loss of
palatability whereas hydrolyzed-milk was also considered
to be sweeter than whole milk. It is well known that
lactose milk can be hydrolyzed upto 90%. However 62%
hydrolyzed milk is found to be clinically as effective as
100% hydrolyzed milk (20) estimated as breath
hydrogen excretion. β-galactosidases from several
bacterial sources have been experimented as candidates
for lactose milk hydrolysis. Solomons and his collegues
have reported a β-galactosidase from Aspergillus niger to
be less effective than the enzyme from Klurveromyces
lactis (Lactaid) for in vivo hydrolysis (21). E. coli βgalactosidase and the lac operon has been extensively
studied by bacterial geneticists and the knowledge has
served immensely in the development of procaryotic and
eucaryotic protein expression systems. However this is
the first study suggesting methodology to evaluate the
utilization of lac mutants as a possible source to manage
clinical lactose intolerance.
It is well known that in bacterial expression systems,
not only introducing peptide sequences, but also culture
conditions, temperature, growth medium composition
and genetic factors have significant impact on protein
integrity (22). This is a concern in recombinant protein
functionality (23). Reasons for this is thought to be a
consequence of the absence of stabilizing ligands or more
likely presence of a different cellular environment which
is incompatible with correct protein folding due to
expression of different stress factors. It has previously
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been stated that small amount of a single abnormal
protein affects the cell’s heat shock protein expression
(23) which leads to an increased protein degradation
rate. With this notion, when manipulating lac i to
maximize yield of β-galactosidase synthesis special
attention should be paid to conserve the native structure
and kinetic efficiency of β-galactosidase as much as
possible, for industrial purposes such as treatment of
milk in clinical management of lactose intolerance. This
study is a simple demonstration of the extent of
conservation of structure under the stated conditions.
The lac i-mutant CSH36 used in this study lacks the
functional tetramer of lac repressor to bind specifically to
lac operator DNA sequences even though it retains
oligomerization and IPTG binding capacity (7). Purified βgalactosidase yielded a Km appearant of 1x10-3 M for
ONPG as a substrate.
The stated Km values for β-galactosidase in E. coli are
0.95x10-4
M for ONPG (o-nitrophenyl-β-Dgalactosidase), 3.23x10-3 M for phenyl-β-galactoside,
3.85x10-3 M for Lactose and 4.45x10-4 M for pnitrophenyl-β-galactoside (25). The molecular weight for
the enzyme has been determined as 540.000 at pH 7.5
(26) and 518.000 at pH 7.6. In this study the molecular
weight of β-galactosidase was estimated as 410.000 kD.
There is a 120.000 kD band and a 50.000 kD band
retained on the purest fraction obtained after ionexchange chromatography. This totals upto 410.000.

This indicates possible proteolysis at the stated conditions
on lac i-mutant. It also possible that some posttranslational
modifications
involving
possible
glycosylation/acylation are missed in the experimental
bacterial environment. The Km appearant was found to
be 1x10-3 M for ONPG as a substrate, higher than what
Weber has found. This is an indication of lower affinity
for substrate as the structure is varied as seen in the
results. It is esential to check the Km for lactose for the
convenience for industrial utility as well as further tests
to compare the efficiency of in vivo hydrolysis with
present alternatives. The purity required for industrial
standard is specific activity >=30 U/mg protein (17). In
this study 170 U/mg protien was achieved with 17%.
Thus, the suggested methodology using the lac i-strain. E.
coli CSH36 is acceptable, however as an alternate to
existing sources for delactosidation performance would
be expected to be low with a low affinity for tested
substrate.
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